Also in that Room: Democratic Biotech-Paid Whores

In my last post, I showed you what a roomful of Republican biotech-paid whores looks like. But in that same room are the following Democratic biotech-paid whores.

Two comments on this. First, both the Republicans and Democrats included a talking point that I haven’t included in these two posts–talking about the necessity to do testing to make sure the biosimilars are interchangeable (Peterr collects the Dem version here). I aspire to do a post collecting all of them to show you bipartisan whoredom in action, if I recover from this tedium.

The other thing: check out the difference in talking points. Sure, the biotech lobbies made Republicans look like assholes. But they basically scripted Democrats into parroting simple five-paragraph essays of the kind you had to write when you were in third grade: Thesis, 1, 2, 3, conclusion. Are they suggesting Democrats can’t handle a script–a frigging script submitted to the record, not read!!–harder than that? If they weren’t already ashamed at being industry whores, they really ought to hang their heads for how stupid the industry made them appear.

“Another significant benefit: jobs jobs jobs!”

Bob Filner

I wanted to draw attention to another significant benefit of this legislation: the creation of new high-paying jobs in this country. Let me repeat that for some of my friends on the other side of the aisle, this bill will create high-paying, high-quality jobs in healthcare delivery, technology and research in the United States.

Yvette Clarke

Another significant benefit of this legislation, which has not received as much attention, will be the creation of new high paying jobs, high quality jobs in healthcare delivery, technology and research in the United States.

Donald Payne

Another significant benefit of this legislation which has not received as much attention will be the creation of new high-paying jobs in this country. Let me repeat that for some of my friends on the other side of the aisle, this bill will create high-paying, high-quality jobs in healthcare delivery, technology and research in the United States.

Bill Pascrell

Another significant benefit of this legislation which has not received as much attention will be the creation of new high-paying jobs in this country. Let me repeat that for some of my friends on the other side of the aisle: this bill will create high-paying, high-quality jobs in health care delivery, technology, and research in the United States.

Phil Hare

With unemployment at its highest level since 1983, another significant benefit of this legislation that should be highlighted is the creation of new high-paying jobs in this country. Let me repeat that for some of my friends on the other side of the aisle, this bill will create high-paying, high-quality jobs in healthcare delivery, technology and research in the United States.

Linda Sanchez

But another significant benefit of this legislation which has not received much attention is its promotion of high-paying research, high tech, and manufacturing jobs. Contrary to the claims that this is a “job killing bill,” in fact, this bill will create thousands of jobs here in the United States.

Robert Brady

“1) An enormous demand for healthcare workers!”

Bob Filner

First, this bill will create enormous demand for healthcare workers, especially in the area of primary care.

Yvette Clarke

First, this bill will create enormous demand for healthcare workers, especially in the area of primary care.

Donald Payne

First, this bill will create enormous demand for healthcare workers, especially in the area of primary care.

Bill Pascrell

First, H.R. 3962 will create enormous demand for health care workers, especially in the area of primary care.

Phil Hare

This bill will additionally create enormous demand for healthcare workers, especially in the area of primary care.

Linda Sanchez

First, this bill will increase demand for healthcare workers, including doctors, nurses, nurse practitioners, physician assistants, home health workers, and more.

Robert Brady

First, this bill will create enormous demand for healthcare workers, especially in the area of primary care.

“2) Health information technologies”

Bob Filner

Second, this bill will continue the efforts we began in the stimulus package to deploy new health information technologies that better manage both the quality of care people receive and the cost at which they receive it.

Yvette Clarke

Second, this bill will continue the efforts we began in the stimulus package to deploy new health information technologies that better manage both the quality of care and the cost of it.

Donald Payne

Bill Pascrell

Second, the Affordable Health Care for America Act will continue the efforts we began in the stimulus package to deploy new health information technologies that better manage both the quality of care people receive and the cost at which they receive it.

Phil Hare

The Affordable Health Care for America Act will continue the efforts this Congress first undertook in the Recovery Act that deployed new health information technologies throughout our healthcare system. These technologies help to better manage both the quality of care people receive and the cost at which they receive it.

Linda Sanchez

Second, this bill will continue the investments begun in the American Recovery and Reinvestment Act, also known as the stimulus bill, to expand the use of health information technology.Health IT will help better manage the quality and cost of care patients receive by eliminating duplicative tests and ensuring that patients don’t receive the wrong medicine or the wrong dose.

Robert Brady

“3) High quality research opportunities!”

Bob Filner

Third, this bill will create high quality research opportunities in this country. The Energy and Commerce Committee enacted a framework for allowing biosimilar competition in this country. This new class of medicines will help lower costs and bring competition to one area that is key to the future of our healthcare system. Biotechnology is on the cutting edge of efforts to reducing costly invasive procedures and allowing our constituents to live healthier and more productive lives.

Yvette Clarke

Third, this bill will create new research opportunities in this country. The Energy and Commerce Committee enacted a framework for allowing biosimilar competition in this country. This new class of medicines will help lower costs and bring competition to one area that is key to the future of our healthcare system. Biotechnology is on the cutting edge of efforts to reduce costly invasive procedures, thereby allowing our constituents to live healthier and more productive lives.

Donald Payne

Bill Pascrell

Third, H.R. 3962 will create high quality research opportunities for America. The legislation under consideration establishes a framework for allowing biosimilar competition in this country. This new class of medicines will help lower costs and bring competition to an area that is a key to the future of our health care system. Biotechnology is on the cutting edge of efforts to reduce costly invasive procedures and allow our constituents to live healthier and more productive lives.

Phil Hare

[presented first in the series] This bill creates a framework for allowing biosimilar competition in this country, which has the potential to lead to a new class of generic biologic medicines that will help lower costs and bring competition to one of the areas that will be key to the future of our healthcare system.

Linda Sanchez

Finally, this bill will promote more of what America already does so well: medical research. By allowing more Americans access to health insurance, this bill will increase the demand for advanced medical technologies that are manufactured right here in America. And by creating a process for the Food and Drug Administration to approve so-called “biosimilar” drugs, this bill will encourage competition in the cutting edge field of biologic drugs. This new class of medicines will help cure and treat more Americans at lower costs.

Robert Brady